Inventor · disambiguated record
Susan Morgan-Lappe
Also filed as: MORGAN-LAPPE SUSAN · MORGAN-LAPPE SUSAN E · MORGAN-LAPPE SUSAN ELIZABETH
9 granted patents·16 pending applications·114 citations·filing 2003–2023
88Inventor score
Top patents by PatentIndex Score
25 records- 0194US9029508B2Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2009·Granted May 12, 2015·57 cites·22 claims
- 0293US9469689B2Therapeutic DLL4 binding proteinsABBVIE INC·Filed 2015·Granted Oct 18, 2016·9 cites·39 claims
- 0390US9132190B2Therapeutic DLL4 binding proteinsABBVIE INC·Filed 2013·Granted Sep 15, 2015·13 cites·46 claims
- 0488US9115195B2Therapeutic DLL4 binding proteinsCHEN MING-JIU·Filed 2011·Granted Aug 25, 2015·13 cites·91 claims
- 0588US8623358B2Therapeutic DLL4 binding proteinsBENATUIL LORENZO·Filed 2010·Granted Jan 7, 2014·13 cites·44 claims
- 0685US10195209B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2016·Granted Feb 5, 2019·5 cites·32 claims
- 0780US9469688B2Therapeutic DLL4 binding proteinsABBVIE INC·Filed 2015·Granted Oct 18, 2016·2 cites·37 claims
- 0878US11045480B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2018·Granted Jun 29, 2021·1 cites·6 claims
- 0977US10188660B2Anti-huLRRC15 antibody drug conjugates and methods for their useABBVIE INC·Filed 2016·Granted Jan 29, 2019·1 cites·27 claims
- 1076US2024115724A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2023·Application pending·0 cites
- 1167US2021009681A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2020·Application pending·0 cites
- 1265US2020255508A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2019·Application pending·0 cites
- 1364US2019111150A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1463US2021145978A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 1560US2019099431A1ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USEABBVIE INC·Filed 2018·Application pending·0 cites
- 1660US2019315855A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2017·Application pending·0 cites
- 1759US2018371071A1Therapeutic DLL4 Binding ProteinsABBVIE INC·Filed 2017·Application pending·0 cites
- 1857US2015017168A1Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2014·Application pending·0 cites
- 1951US2010260668A1Dual Variable Domain Immunoglobulins and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2051US2015104452A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 2149US2016319026A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2016·Application pending·0 cites
- 2248US2011263827A1Dual Variable Domain Immunnoglobulins and Uses ThereofABBOTT LAB·Filed 2010·Application pending·0 cites
- 2343US2004180848A1Method of killing cancer cellsFiled 2004·Application pending·0 cites
- 2440US2004180844A1Method of killing cancer cellsFiled 2003·Application pending·0 cites
- 2537US2011223176A1Basigin binding proteinsABBOTT LAB·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →